Hair News

FDA OKs Addyi, a Libido-Enhancing Drug for Women After Menopause
Hair News

FDA OKs Addyi, a Libido-Enhancing Drug for Women After Menopause

**New Treatment Option for Low Sex Drive in Postmenopausal Women** As part of its ongoing efforts to improve women's health, the FDA has expanded the approval of Addyi (flibanserin) to treat low sex drive in postmenopausal women up to age 65.

13.01.2026 2 min